CAS 2066488-39-7

6-[[(1S)-1-(4-Chlorophenyl)ethyl]amino]-1-cyclopentyl-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one

CAS: 2066488-39-7

Formel: C₁₈H₂₀ClN₅O

Reinheit: 98%

Molekulargewicht: 357.8373

Ref: IN-DA01ENIN

PDE9-IN-(S)-C33

CAS: 2066488-39-7

PDE9-IN-(S)-C33

Reinheit: ≥98%

Molekulargewicht: 357.84g/mol

Ref: 54-BUP07738

PDE9-IN-(S)-C33

CAS: 2066488-39-7

PDE9-IN-(S)-C33 is a phosphodiesterase inhibitor that is used in the treatment of heart diseases such as cardiac hypertrophy. PDE9-IN-(S)-C33 inhibits the activity of phosphodiesterase (PDE) type 9, which breaks down cyclic guanosine monophosphate (cGMP). This leads to an increase in intracellular cGMP levels and an inhibition of cardiac hypertrophy. PDE9-IN-(S)-C33 also has a beneficial effect on neonatal rat cardiomyocytes, which may be due to its ability to inhibit transition from hyperplasia to hypertrophy.

Formel: C₁₈H₂₀ClN₅O

Reinheit: Min. 95%

Molekulargewicht: 357.8 g/mol

Ref: 3D-RHD48839

PDE9-IN-(S)-C33

CAS: 2066488-39-7

PDE9-IN-(S)-C33: potent PDE9 inhibitor with 11 nM IC50, for CNS diseases and diabetes study.

Formel: C₁₈H₂₀ClN₅O

Reinheit: 98.75%

Farbe und Form: Solid

Molekulargewicht: 357.84

Ref: TM-T28352